[Use of neuromuscular blocking agents and reversal of blockade: guidelines from Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor].
Alvarez Gómez
J A
JA
Servicio de Anestesiología y Reanimación, Hospital Universitario Santa María del Rosell, Cartagena, Murcia.
Ariño Irujo
J J
JJ
Errando Oyonarte
C L
CL
Matínez Torrente
F
F
Roigé i Solé
J
J
Gilsanz Rodríguez
F
F
D000465:Algorithms; D001285:Atropine / Q000627:therapeutic use; D000075202:Contraindications; D003422:Critical Care / Q000379:methods / Q000592:standards; D055191:Delayed Emergence from Anesthesia; D019317:Evidence-Based Medicine; D006801:Humans; D007442:Intubation, Intratracheal; D016343:Monitoring, Intraoperative; D009388:Neostigmine / Q000627:therapeutic use; D019148:Neuromuscular Blockade / Q000009:adverse effects / Q000379:methods / Q000592:standards*; D009466:Neuromuscular Blocking Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000145:classification
D009466:Neuromuscular Blocking Agents; D009388:Neostigmine; D001285:Atropine